Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Strengthening National Capacity in Malaria and Other Infectious Disease Operations Research, Funding Opportunity Announcement (FOA) CK09-003, 19564 [E9-9743]
Download as PDF
19564
Federal Register / Vol. 74, No. 81 / Wednesday, April 29, 2009 / Notices
Background and Brief Description
Reducing congenital syphilis is a
national objective in the DHHS Report
entitled ‘‘Healthy People 2010 (Vol. I
and II)’’. Objective 25–9 of the DHHS
document states the goal to ‘‘reduce
congenital syphilis to 1 new case per
100,000 live births’’. In order to meet
this national objective, an effective
surveillance system for congenital
Report’’ data collection form will be
removed because several states have
begun to use a 5-digit (rather than 4digit) FIPS code for city, and CDC data
systems cannot accommodate the new
codes.
The congenital syphilis data will
continue to be used to develop
intervention strategies and to evaluate
ongoing control efforts. There is no cost
to respondents other than their time.
syphilis must be continued to monitor
current levels of disease and progress
towards the year 2010 objective. The
purpose of the revision is to
accommodate minor change to the
‘‘Congenital Syphilis (CS) Case
Investigation and Report Form’’
(CDC73.126). In the proposed revision,
the ‘‘reporting city’’ and ‘‘resident city’’
information blocks in the ‘‘Congenital
Syphilis (CS) Case Investigation and
ESTIMATE OF ANNUALIZED BURDEN TABLE
No. of
responses per
respondent
No. of
respondents
Average
burden per
response
(in hours)
Total burden
(in hours)
Type of respondents
Name of form
State and local health departments ..
Congenital Syphilis (CS) Case Investigation and Report.
18
11
20/60
66
Total ...........................................
...........................................................
18
........................
........................
66
Dated: April 23, 2009.
Maryam I. Daneshvar,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. E9–9772 Filed 4–28–09; 8:45 am]
BILLING CODE 4163–18–P
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: April 17, 2009.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E9–9743 Filed 4–28–09; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
BILLING CODE 4163–18–P
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Strengthening
National Capacity in Malaria and Other
Infectious Disease Operations
Research, Funding Opportunity
Announcement (FOA) CK09–003
pwalker on PROD1PC71 with NOTICES
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting.
Time And Date: 12 p.m.–3 p.m., June 11,
2009 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c) (4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters To Be Discussed: The meeting will
include the review, discussion, and
evaluation of ‘‘Strengthening National
Capacity in Malaria and Other Infectious
Disease Operations Research, Funding
Opportunity Announcement (FOA) CK09–
003.’’
Contact Person For More Information:
Wendy Carr, PhD, CDC, 1600 Clifton Road,
NE., Mailstop D60, Atlanta, GA 30333,
Telephone: (404) 498–2276.
VerDate Nov<24>2008
17:48 Apr 28, 2009
Jkt 217001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel.
Date: May 5, 2009.
PO 00000
Frm 00080
Fmt 4703
Sfmt 4703
Time: 8 a.m. to 12 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852, (Telephone
Conference Call)
Contact Person: William C. Benzing, PhD,
Scientific Review Administrator, Scientific
Review Branch, Division Of Extramural
Research, NINDS/NIH/DHHS/Neuroscience
Center, 6001 Executive Boulevard, Suite
3204, MSC 9529, Bethesda, MD 20892, (301)
496–0660, benzingw@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS)
Dated: April 23, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–9863 Filed 4–28–09; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Mental Health;
Amended Notice of Meeting
Notice is hereby given of a change in
the meeting of the National Institute of
Mental Health Special Emphasis Panel,
May 14, 2009, 9 a.m. to May 14, 2009,
5 p.m., Melrose Hotel, 2430
Pennsylvania Ave., NW., Washington,
DC 20037 which was published in the
Federal Register on April 17, 2009, 74
FR N17874.
The meeting will be held on June 2,
2009. The time and meeting location
E:\FR\FM\29APN1.SGM
29APN1
Agencies
[Federal Register Volume 74, Number 81 (Wednesday, April 29, 2009)]
[Notices]
[Page 19564]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-9743]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control Special
Emphasis Panel (SEP): Strengthening National Capacity in Malaria and
Other Infectious Disease Operations Research, Funding Opportunity
Announcement (FOA) CK09-003
In accordance with Section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the aforementioned meeting.
Time And Date: 12 p.m.-3 p.m., June 11, 2009 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the public in accordance
with provisions set forth in Section 552b(c) (4) and (6), Title 5
U.S.C., and the Determination of the Director, Management Analysis
and Services Office, CDC, pursuant to Public Law 92-463.
Matters To Be Discussed: The meeting will include the review,
discussion, and evaluation of ``Strengthening National Capacity in
Malaria and Other Infectious Disease Operations Research, Funding
Opportunity Announcement (FOA) CK09-003.''
Contact Person For More Information: Wendy Carr, PhD, CDC, 1600
Clifton Road, NE., Mailstop D60, Atlanta, GA 30333, Telephone: (404)
498-2276.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities, for both CDC and the Agency for Toxic Substances and
Disease Registry.
Dated: April 17, 2009.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. E9-9743 Filed 4-28-09; 8:45 am]
BILLING CODE 4163-18-P